| Literature DB >> 24365115 |
Koen Sandra1, Isabel Vandenheede2, Pat Sandra2.
Abstract
Protein biopharmaceuticals such as monoclonal antibodies and therapeutic proteins are currently in widespread use for the treatment of various life-threatening diseases including cancer, autoimmune disorders, diabetes and anemia. The complexity of protein therapeutics is far exceeding that of small molecule drugs; hence, unraveling this complexity represents an analytical challenge. The current review provides the reader with state-of-the-art chromatographic and mass spectrometric tools available to dissect primary and higher order structures, post-translational modifications, purity and impurity profiles and pharmacokinetic properties of protein therapeutics.Entities:
Keywords: Biopharmaceutical; Chromatography; Mass spectrometry; Monoclonal antibody; Therapeutic protein
Mesh:
Substances:
Year: 2013 PMID: 24365115 DOI: 10.1016/j.chroma.2013.11.057
Source DB: PubMed Journal: J Chromatogr A ISSN: 0021-9673 Impact factor: 4.759